Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease

被引:220
|
作者
Ryu, Eun-Sun [1 ]
Kim, Mi Jin [1 ]
Shin, Hyun-Soo [1 ]
Jang, Yang-Hee [1 ]
Choi, Hack Sun [1 ]
Jo, Inho [2 ]
Johnson, Richard J. [3 ]
Kang, Duk-Hee [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Div Nephrol, Dept Internal Med,Ewha Med Res Ctr, Seoul 158710, South Korea
[2] Ewha Womans Univ, Sch Med, Dept Mol Med, Ewha Med Res Ctr, Seoul 158710, South Korea
[3] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA
基金
新加坡国家研究基金会;
关键词
uric acid; chronic kidney disease; renal tubular cells; epithelial-to-mesenchymal transition; E-cadherin; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; DOWN-REGULATION; BLOOD-PRESSURE; RISK-FACTORS; HYPERURICEMIA; SNAIL; PROLIFERATION; ALLOPURINOL; PROGRESSION;
D O I
10.1152/ajprenal.00560.2012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol 304: F471-F480, 2013. First published January 2, 2013; doi:10.1152/ajprenal.00560.2012.-Recent experimental and clinical studies suggest a causal role of uric acid in the development of chronic kidney disease. Most studies have focused on uric acid-induced endothelial dysfunction, oxidative stress, and inflammation in the kidney. The direct effects of uric acid on tubular cells have not been studied in detail, and whether uric acid can mediate phenotypic transition of renal tubular cells such as epithelial-to-mesenchymal transition (EMT) is not known. We therefore investigated whether uric acid could alter E-cadherin expression and EMT in the kidney of hyperuricemic rats and in cultured renal tubular cells (NRK cells). Experimental hyperuricemia was associated with evidence of EMT before the development of significant tubulointerstitial fibrosis at 4 wk, as shown by decreased E-cadherin expression and an increased alpha-smooth muscle actin (alpha-SMA). Allopurinol significantly inhibited uric acid-induced changes in E-cadherin and alpha-SMA with an amelioration of renal fibrosis at 6 wk. In cultured NRK cells, uric acid induced EMT, which was blocked by the organic anion transport inhibitor probenecid. Uric acid increased expression of transcriptional factors associated with decreased synthesis of E-cadherin (Snail and Slug). Uric acid also increased the degradation of E-cadherin via ubiquitination, which is of importance since downregulation of E-cadherin is considered to be a triggering mechanism for EMT. In conclusion, uric acid induces EMT of renal tubular cells decreasing E-cadherin synthesis via an activation of Snail and Slug as well as increasing the degradation of E-cadherin.
引用
收藏
页码:F471 / F480
页数:10
相关论文
共 50 条
  • [1] Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Feig, Daniel I.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (06) : 526 - 530
  • [2] Uric acid and progression of chronic kidney disease
    Weaver, Donald J., Jr.
    PEDIATRIC NEPHROLOGY, 2019, 34 (05) : 801 - 809
  • [3] The role of uric acid in chronic kidney disease patients
    Hsieh, Yao-Peng
    Chang, Chia-Chu
    Yang, Yu
    Wen, Yao-Ko
    Chiu, Ping-Fang
    Lin, Chi-Chen
    NEPHROLOGY, 2017, 22 (06) : 441 - 448
  • [4] Association of Uric Acid and Left Ventricular Mass Index With Renal Outcomes in Chronic Kidney Disease
    Chen, Szu-Chia
    Chang, Jer-Ming
    Yeh, Shin-Meng
    Su, Ho-Ming
    Chen, Hung-Chun
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (02) : 243 - 249
  • [5] Uric acid and chronic kidney disease: which is chasing which?
    Johnson, Richard J.
    Nakagawa, Takahiko
    Jalal, Diana
    Gabriela Sanchez-Lozada, Laura
    Kang, Duk-Hee
    Ritz, Eberhard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (09) : 2221 - 2228
  • [6] The association of renal tubular inflammatory and injury markers with uric acid excretion in chronic kidney disease patients
    Zheng, Yuqi
    Guan, Haochen
    Zhou, Xun
    Xu, Ying
    Fu, Chensheng
    Xiao, Jing
    Ye, Zhibin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (05) : 923 - 932
  • [7] Uric acid and incident chronic kidney disease in dyslipidemic individuals
    Barkas, Fotios
    Elisaf, Moses
    Liberopoulos, Evangelos
    Kalaitzidis, Rigas
    Liamis, George
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (07) : 1193 - 1199
  • [8] Serum uric acid and the risk of hypertension and chronic kidney disease
    Feig, Daniel I.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (02) : 176 - 185
  • [9] The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia
    Tsuji, Takayuki
    Ohishi, Kazuhisa
    Takeda, Asumi
    Goto, Daiki
    Sato, Taichi
    Ohashi, Naro
    Fujigaki, Yoshihide
    Kato, Akihiko
    Yasuda, Hideo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1300 - 1308
  • [10] Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease
    Matsukuma, Yuta
    Masutani, Kosuke
    Tanaka, Shigeru
    Tsuchimoto, Akihiro
    Haruyama, Naoki
    Okabe, Yasuhiro
    Nakamura, Masafumi
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2017, 266 : 121 - 127